Applications of Genomics in Melanoma Oncogene Discovery

被引:26
作者
Berger, Michael F. [2 ]
Garraway, Levi A. [1 ,2 ,3 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA
[3] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA
关键词
Melanoma; Oncogene; DNA sequencing; Microarrays; Gene amplification; Targeted therapy; CUTANEOUS MALIGNANT-MELANOMA; BLADDER-CARCINOMA ONCOGENE; N-RAS MUTATIONS; HUMAN CANCER; IMATINIB MESYLATE; METASTATIC MELANOMA; TRANSFORMING GENES; BRAF MUTATIONS; LUNG-CANCER; COPY NUMBER;
D O I
10.1016/j.hoc.2009.03.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The identification of recurrent alterations in the melanoma genome has provided key insights into the biology of melanoma genesis and progression. These discoveries have come about as a result of the systematic deployment and integration of diverse genomic technologies, including DNA sequencing, chromosomal copy number analysis, and gene expression profiling. Here, the discoveries of several key melanoma oncogenes affecting critical cell pathways are described and the role played by evolving genomics technologies in melanoma oncogene discovery is examined. These advances are being exploited to improve prognosis and treatment of melanoma patients through the development of genome-based diagnostic and targeted therapeutic avenues.
引用
收藏
页码:397 / +
页数:19
相关论文
共 50 条
[41]   From oncogene to network addiction: the new frontier of cancer genomics and therapeutics [J].
Tonon, Giovanni .
FUTURE ONCOLOGY, 2008, 4 (04) :569-577
[42]   Functional genomics and cancer drug target discovery [J].
Moody, Susan E. ;
Boehm, Jesse S. ;
Barbie, David A. ;
Hahn, William C. .
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (03) :284-293
[43]   Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications [J].
Bida, Meshack ;
Miya, Thabiso Victor ;
Hull, Rodney ;
Dlamini, Zodwa .
FRONTIERS IN IMMUNOLOGY, 2024, 15
[44]   Identification of TDP-43 as an oncogene in melanoma and its function during melanoma pathogenesis [J].
Zeng, Qinghai ;
Cao, Ke ;
Liu, Rui ;
Huang, Jinhua ;
Xia, Kun ;
Tang, Jintian ;
Chen, Xiang ;
Zhou, Ming ;
Xie, Huiqing ;
Zhou, Jianda .
CANCER BIOLOGY & THERAPY, 2017, 18 (01) :8-15
[45]   Applications of fuzzy logic in genomics [J].
Ressom, H ;
Natarajan, P ;
Varghese, RS ;
Musavi, MT .
FUZZY SETS AND SYSTEMS, 2005, 152 (01) :125-138
[46]   A Variant in a MicroRNA complementary site in the 3′ UTR of the KIT oncogene increases risk of acral melanoma [J].
Godshalk, S. E. ;
Paranjape, T. ;
Nallur, S. ;
Speed, W. ;
Chan, E. ;
Molinaro, A. M. ;
Bacchiocchi, A. ;
Hoyt, K. ;
Tworkoski, K. ;
Stern, D. F. ;
Sznol, M. ;
Ariyan, S. ;
Lazova, R. ;
Halaban, R. ;
Kidd, K. K. ;
Weidhaas, J. B. ;
Slack, F. J. .
ONCOGENE, 2011, 30 (13) :1542-1550
[47]   Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma [J].
Martinez-Vila, Clara ;
Teixido, Cristina ;
Aya, Francisco ;
Martin, Roberto ;
Gonzalez-Navarro, Europa Azucena ;
Alos, Llucia ;
Castrejon, Natalia ;
Arance, Ana .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (02)
[48]   CRAF R391W is a melanoma driver oncogene [J].
Atefi, Mohammad ;
Titz, Bjoern ;
Tsoi, Jennifer ;
Avramis, Earl ;
Le, Allison ;
Ng, Charles ;
Lomova, Anastasia ;
Lassen, Amanda ;
Friedman, Michael ;
Chmielowski, Bartosz ;
Ribas, Antoni ;
Graeber, Thomas G. .
SCIENTIFIC REPORTS, 2016, 6
[49]   Melanoma genomics - will we go beyond BRAF in clinics? [J].
Mirek, Justyna ;
Bal, Wieslaw ;
Olbryt, Magdalena .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (09)
[50]   Mouse pigmentation mutants help identify a uveal melanoma oncogene [J].
Hayward, Nicholas K. .
PIGMENT CELL & MELANOMA RESEARCH, 2009, 22 (01) :2-3